Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.18 USD | +0.46% | -5.65% | -68.64% |
Apr. 29 | Immix Biopharma Gets Orphan Drug Label in Europe For Multiple Myeloma Treatment | MT |
Apr. 18 | Immix Biopharma on Track to Dose First Patients with AL Amyloidosis Therapy by Mid-Year | MT |